SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-006432
Filing Date
2021-01-22
Accepted
2021-01-22 06:02:10
Documents
12
Period of Report
2021-01-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213777d1_8k.htm   iXBRL 8-K 26683
  Complete submission text file 0001104659-21-006432.txt   199835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ymab-20210121.xsd EX-101.SCH 3178
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymab-20210121_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymab-20210121_pre.xml EX-101.PRE 22705
5 EXTRACTED XBRL INSTANCE DOCUMENT tm213777d1_8k_htm.xml XML 3600
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 21543672
SIC: 2834 Pharmaceutical Preparations